Filing Details

Accession Number:
0001209191-20-058026
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-12 17:03:48
Reporting Period:
2020-11-11
Accepted Time:
2020-11-12 17:03:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358762 Reata Pharmaceuticals Inc RETA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1034320 D Michael Wortley 5320 Legacy Drive
Plano TX 75024
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2020-11-11 51,429 $0.00 51,429 No 4 C Direct
Class A Common Stock Disposition 2020-11-11 2,112 $175.94 49,317 No 4 S Direct
Class A Common Stock Disposition 2020-11-11 2,190 $177.24 47,127 No 4 S Direct
Class A Common Stock Disposition 2020-11-11 9,386 $178.10 37,741 No 4 S Direct
Class A Common Stock Disposition 2020-11-11 16,608 $179.05 21,133 No 4 S Direct
Class A Common Stock Disposition 2020-11-11 10,552 $180.24 10,581 No 4 S Direct
Class A Common Stock Disposition 2020-11-11 7,971 $180.93 2,610 No 4 S Direct
Class A Common Stock Disposition 2020-11-11 2,100 $182.06 510 No 4 S Direct
Class A Common Stock Disposition 2020-11-11 410 $182.64 100 No 4 S Direct
Class A Common Stock Disposition 2020-11-11 100 $184.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class B Common Stock Employee Stock Option (right to buy) Disposition 2020-11-11 12,245 $0.00 12,245 $11.00
Class B Common Stock Employee Stock Option (right to buy) Disposition 2020-11-11 39,184 $0.00 39,184 $17.43
Class A Common Stock Class B common stock Acquisiton 2020-11-11 12,245 $11.00 12,245 $0.00
Class A Common Stock Class B common stock Acquisiton 2020-11-11 39,184 $17.43 39,184 $0.00
Class A Common Stock Class B common stock Disposition 2020-11-11 51,429 $0.00 51,429 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-05-25 No 4 M Direct
0 2025-03-31 No 4 M Direct
12,245 No 4 M Direct
51,429 No 4 M Direct
0 No 4 C Direct
Footnotes
  1. The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $175.61 to $175.585. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $176.68 to $177.60. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $177.61 to $178.60. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $178.62 to $179.47. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $179.61 to $180.565. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $180.63 to $181.57. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $181.62 to $182.60. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $182.61 to $182.66. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  10. The options, representing a right to purchase a total of 39,185 shares, vested in sixteen equal quarterly installments beginning on August 25, 2016.
  11. The options, representing a right to purchase a total of 39,184 shares, vested as to 14,204 shares on April 1, 2016 and the remainder vested in twelve equal quarterly installments thereafter.